• Antimalarial drugs have selective actions on the different phases of the parasite life cycle • Causal prophylaxis drugs prevent the establishment of the parasite in the liver and blood schizontocidal drugs attack the parasites in RBCs, preventing or terminating the clinical attack • Tissue schizontocides act on pre-erythrocytic forms in the liver • Gametocytocidal drugs destroy the sexual forms of the parasite in the blood • Hypnozoitocidal kills the dormant hypnozoites in the liver (responsible for relapses in P. ovale and P. vivax) • Sporontocidal drugs- inhibit the dev of oocysts on the stomach wall of the mosquito that has fed on the human gametocytes carries so that the mosquito cannot transmit the infection • People who have by repeated exposure to infection, acquire a degree of immunity can be cured or protected much more easily by drugs than those who have not Uses of antimalarial drugs
Efficacy of antimalarial is determined by:-
• The spp of malaria parasites e.g. spp with hypnozoites stage are eradicated by 8-aminoquinoline- primaquine or tafenoquine • Parasites sensitivity to drugs:- Pf resistance to Chloroquine + SP • The host’s degree of immunity to the parasite:- treatment of immune vs treatment of non-immune • Analysis of the benefits of treatment vs the risks of adverse effects • Drug costs: many drugs are unaffordable to many patients • Practicability of the treatment regimen: for both outpatient and in patients treatment The main uses of antimalarial drugs are:- i. Protective (prophylactic) ii. Curative (therapeutic):- therapy of established infection iii. Preventive of transmission:- drug effects on gametocytes + interruption of sporogony in the insect The main antimalarial drugs • Artemisinins:- (derivatives- Artemether,arteether and artesunate) Action:- destroy the parasites membrane by oxidative action • Atovaquone:- affects the maturations of trophozoites and gametocytes of P. falciparum - Used in combination with proguanil for treatment and prophylaxis of multiresistant falciparum malaria • Lumefantrine:- used in combination with Artemether (Co-Artemether) for the treatment of uncomplicated multiresistant falciparum malaria • Chloroquine and Amodiaquine:-acts against stages of malaria lifecycle which actively digest haemoglobin within the erythrocytes. The drug target the food vacuole of the parasites - The drugs are effective against P. vivax, P. ovale and P. malariae - P. falciparum are resistant to Chloroquine - Oral Chloroquine is used for the treatment and prophylaxis of vivax, ovale and malariae malarias and for uncomplicated Chloroquine-sensitive falciparum malaria The main antimalarial drugs • Amodiaquine:- Chloroquine-resistant strains of P. falciparum may remain sensitive to Amodiaquine - Amodiaquine is no longer recommended for prophylaxis due hepatic effects • Clindamycin:- Lincosamide antibiotic and has blood schizontocidal activity of against Pf and must be used in combination - Is effective against multiresistant Pf in South America, Africa, Asia • Halofantrine:- efficacy against the multidrug resistant Pf and is used in combination with artemesinin derivatives. Monotherapy resistance have been reported • Mefloquine:- used for the prophylaxis and treatment of uncomplicated multiresistant falciparum malaria - In combination with artesunate- effective against uncomplicated falciparum malaria in areas with Mefloquine resistance • Primaquine and Tefenoquine:- Primaquine is used for the radical cure of vivax and ovale malarias as a community transmission blocking (gametocytocidal) drug against P. falciparum The main antimalarial drugs • Tafenoquine:- hypnozoitocide, blood schizontocide and gametocytocidal • Proguanil and chlorproguanil:- Proguanil used in combination with Chloroquine for the prophylaxis of mildly Chloroquine resistant falciparum malaria and in combination with Atovaquone • Pyrimethamine:- In combination with dapsone (Maloprim or Deltaprim) is used as prophylaxis of mildly Chloroquine resistant falciparum malaria - Used in combination with sulfadoxine (Fansidar) or with sulfalene (Metakelfin) for treatment of uncomplicated Chloroquine resistant falciparum malaria - Fansidar (SP) for IPTp-SP during pregnancy • Pyronaridine:- used in both oral and parenteral forms for the treament of chloroquine-resistant Pf malaria - Used for treament of uncomplicated chloroquine resistant falciparum malaria The main antimalarial drugs • Quinine:- interferes with parasite metabolism of haemin, a toxic product of haemoglobin digestion - Is the drug of choice for the parenteral treatment of severe and the oral treatment of uncomplicated chloroquine- resistant falciparum malaria - The drug is also recommend during pregnancy • Sulphanamides and sulphones:- in combination with pyrimethamine (e.g. Fansidar) are used for treatment of chloroquine-resistant falciparum malaria OR Dapsone + Pyrimethamine (Maloprim) is used for the prophylaxis of mildly chloroquine-resistant falciparum malaria • Tetracycline:- Used in combination with quinine in the treatment of severe and uncomplicated multi-resistant falciparum malaria - Doxycycline is used for the prophylaxis of multiresistant falciparum malaria. Combination therapy • Why combination? Monotherapy results in rapid dev. of drug resistance - Example the use of Mefloquine 25mg/kg parasite resistance was 50% in 1994 and treatment was changed to mefloquine 25mg/kg + Artesunate 4 mg/kg and cure rate is 95% - Artesunate rapid acting blood schizontocide reducing parasite density + inhibitory effect on gametocytes • An important aspect of combination therapy is mutual simultaneous protection offered to each of the partner drugs. No parasites is exposed to one drug in the absence of the other. • Further combination therapy allows the dose of individual drugs to be reduced Drugs used in combination therapy • In fixed ratio combination therapy- the two drugs are formulated in a single tablet 1. Lumefantrine + artemether (Co-artemether) 2. Amodiaquine + artesunate (understand) 3. Sulphadoxine-pyrimethamine + artesunate 4. Artemether + Lumefantrine